Nurse Practitioner, Adult Health · Florence, SC
NPI
1336560903
Since 2013
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
360 N Irby St
Florence, SC, 29501
Phone (843) 667-9414
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,836
197 services
Medicare patients, 2024
100
Average age 65
Drug cost, 2024
$3.8M
6,125 prescriptions
Company payments, 2025
$841
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christy H Evans was code 83036 (blood count), 192 times for 99 patients. In total Christy H Evans billed 197 services in 3 codes, and Medicare paid $1,836.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-06-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 83036 Blood Count | Office | 192 | 99 | $9.40 | $1,804 |
By year: 2022 $1,305 for 140 services; 2023 $1,600 for 170 services; 2024 $1,836 for 197 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 192 | 99 | $9.40 | $1,804 |
Medicare prescription drug claims, 2024
In 2024, the drug Christy H Evans prescribed most often to Medicare patients was Ozempic (Semaglutide), with 1,201 prescriptions and refills. In total Christy H Evans wrote 6,125 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 1,201 | 1,543 | 235 | $1.4M |
| Jardiance Empagliflozin | 574 | 967 | 136 | $572K |
| Metformin Hcl Er Metformin Hcl | 560 | 1,002 | 142 | $3,156 |
| Tresiba Flextouch U-100 Insulin Degludec | 405 | 842 | 114 | $231K |
| Metformin Hcl Generic | 284 | 579 | 78 | $1,536 |
| Mounjaro Tirzepatide | 279 | 317 | 44 | $338K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 232 | 474 | 65 | $29K |
| Novolog Flexpen Insulin Aspart | 221 | 443 | 75 | $46K |
| Tresiba Flextouch U-200 Insulin Degludec | 219 | 376 | 57 | $190K |
| Humalog Kwikpen U-100 Insulin Lispro | 201 | 399 | 69 | $41K |
| Farxiga Dapagliflozin Propanediol | 163 | 294 | 46 | $169K |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 152 | 286 | 60 | $14K |
| Trulicity Dulaglutide | 99 | 126 | 22 | $122K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 97 | 190 | 50 | $9,776 |
| Tradjenta Linagliptin | 90 | 128 | 24 | $65K |
Brand drugs: 4,484 claims; generic drugs: 1,056 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christy H Evans $841 ($841 in general payments such as food, travel and fees) from 13 companies. The largest payer was Insulet Corporation with $157.
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation PODD | 5 | $157 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $129 |
| Lilly USA, LLC LLY | 13 | $116 |
| Beta Bionics, Inc. BBNX | 4 | $96.99 |
| CeQur Corporation | 1 | $82.5 |
| Dexcom, Inc. DXCM | 3 | $71.94 |
| Abbott Laboratories ABT | 3 | $56.84 |
| Tandem Diabetes Care, Inc. TNDM | 2 | $38.22 |
| Novo Nordisk Inc NVO | 2 | $29.33 |
| Abbvie Inc. ABBV | 1 | $16.74 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.